T4H-43087-21158
2 vaccinations
1 coded response
17 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 292 / SC
- Registered
- 2022-07-22
- Relationship
- Child or adolescent in my care
- Guardian
- T7E-33208-00821
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-07-21
Dose 1 — Pfizer-BioNTech
-
2022-07-22
Registered in v-safe
-
2022-07-22
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Good · Site: Pain · Fever · NoneUnder 3 check-in
- 2022-07-23
- 2022-07-24
- 2022-07-25
- 2022-07-26
- 2022-07-27
- 2022-07-28
- 2022-08-04
-
2022-08-11
Dose 2 — Pfizer-BioNTech
- 2022-08-12
- 2022-08-13
- 2022-08-16
- 2022-08-18
- 2022-08-25
-
2022-09-01
Survey response — day 21, dose 2, under 3MedDRA: Decreased appetite, Lethargy, Pyrexia — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Slight fever, lethargy, lack of appetiteMedDRA releases: 2024-11 · check-in free text available
- 2022-09-08
- 2022-09-17
- 2022-09-22
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-07-21 | Pfizer-BioNTech | No |
| 2 | 2022-08-11 | Pfizer-BioNTech | No |
Free text
Release 12 (Under 3) — day 21, dose 2, under 3
Symptoms: Slight fever, lethargy, lack of appetite
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Decreased appetite | · | · | ✓ |
| SD | Lethargy | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release